Skip to content

Assess the Effects of Infant Formula on Infant Stool Characteristics, Behaviour and Parental Experience in Everyday Situations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02911454
Enrollment
252
Registered
2016-09-22
Start date
2016-07-31
Completion date
2017-08-31
Last updated
2017-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

A prospective, multi-country, open label study to describe the stool characteristics and behaviour as well as the parents' experience in infants receiving a recently launched infant formula in a real life situation.

Interventions

OTHERInfant formula

Sponsors

Nutricia Research
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
1 Hours to 6 Weeks
Healthy volunteers
No

Inclusion criteria

* Healthy term infants, gestational age up to and including 37 weeks and 42 weeks and below. Healthy is defined as no supervision or medical treatment by a medical specialist. Further more to be determined by HCP. * Birth weight between 2.5 - 4.5 KG (within normal range for gestational age and sex) * Infants up to 6 weeks of postnatal age (Including day 42) * Receiving exclusively or at least 1 complete infant formula feeding per day at study inclusion (retrospectively exclusively or partly formula fed) * Willingness to change from their regular infant formula to study product * Parents' or legal guardians' aged up to and including 18 years, written, informed consent.

Exclusion criteria

* Infants with a congenital condition and / or previous or current illness and (or) medication that could interfere with the study * Infants with established or suspected cows milk allergy, lactose intolerance, galactosaemia or infants on a prescribed fibre free (e.g. prebiotic oligosaccharides) diet * Participation in any other studies involving investigational or marketed products concomitantly or within 2 weeks prior to entry into the study * Investigator's uncertainty about the willingness of the parents / legal guardians to comply with the protocol requirements.

Design outcomes

Primary

MeasureTime frameDescription
Stool consistency measured by Amsterdam Stool Scale.15 monthsWill be reported in diaries completed by the parents.
Crying time15 monthsWill be reported in diaries completed by the parents.
Stool frequency15 monthsWill be reported in diaries completed by the parents.

Secondary

MeasureTime frameDescription
Eating behaviour15 monthsBaby Eating Behaviour Questionnaire
Parental experience of child behaviour15 monthsPedsQL,
Impact on family life15 monthsFamPedsQL

Countries

Austria, Poland, Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026